Cameron McKinzie

17PUBLICATIONS
19CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiologyInfant and child healthChiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 28, 2025
Challenges and Opportunities for Pharmacogenomics in the Care of People With Cystic Fibrosis.

Cameron J McKinzie, Paul M Beringer, Aleah S Groman

|Aug 08, 2025
Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis.

Emma M Tillman, Cameron McKinzie, Dave Young

|Mar 11, 2025
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis.

Cindy L Williams, Joanna Billings, Harriet McGowan

|Dec 20, 2024
Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series.

Charissa W Kam, Cameron J McKinzie, Nicole E Omecene

|Aug 30, 2024
Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy.

Cameron J McKinzie, Stephanie R Duehlmeyer, Charissa W Kam

|Apr 17, 2024
Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor.

Richard De Vuyst, Charissa W Kam, Cameron J McKinzie

Pageof 3